Vaxart Inc (VXRT)
0.7095
+0.05
(+7.76%)
USD |
NASDAQ |
Apr 26, 16:00
0.7095
0.00 (0.00%)
After-Hours: 16:52
Vaxart Shareholders Equity (Quarterly): 57.80M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 57.80M |
September 30, 2023 | 71.52M |
June 30, 2023 | 85.07M |
March 31, 2023 | 89.75M |
December 31, 2022 | 110.60M |
September 30, 2022 | 122.31M |
June 30, 2022 | 143.09M |
March 31, 2022 | 166.36M |
December 31, 2021 | 187.53M |
September 30, 2021 | 204.95M |
June 30, 2021 | 199.78M |
March 31, 2021 | 176.24M |
December 31, 2020 | 123.40M |
September 30, 2020 | 131.68M |
June 30, 2020 | 40.24M |
March 31, 2020 | 31.29M |
December 31, 2019 | 12.95M |
September 30, 2019 | 18.90M |
June 30, 2019 | 15.84M |
March 31, 2019 | 12.58M |
December 31, 2018 | 11.24M |
September 30, 2018 | 15.99M |
June 30, 2018 | 22.35M |
March 31, 2018 | 31.11M |
December 31, 2017 | 10.80M |
Date | Value |
---|---|
September 30, 2017 | 13.90M |
June 30, 2017 | 18.70M |
March 31, 2017 | 24.20M |
December 31, 2016 | 28.00M |
September 30, 2016 | 36.60M |
June 30, 2016 | 46.20M |
March 31, 2016 | 52.70M |
December 31, 2015 | 57.50M |
September 30, 2015 | 63.50M |
June 30, 2015 | 69.50M |
March 31, 2015 | 81.50M |
December 31, 2014 | 82.40M |
September 30, 2014 | 77.90M |
June 30, 2014 | 86.90M |
March 31, 2014 | 96.00M |
December 31, 2013 | 64.20M |
September 30, 2013 | 64.90M |
June 30, 2013 | 68.00M |
March 31, 2013 | 80.10M |
December 31, 2012 | 78.96M |
September 30, 2012 | 29.97M |
June 30, 2012 | 57.34M |
March 31, 2012 | 59.41M |
December 31, 2011 | 58.87M |
September 30, 2011 | 60.69M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
12.95M
Minimum
Dec 2019
204.95M
Maximum
Sep 2021
104.70M
Average
110.60M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
Novavax Inc | -716.93M |
aTyr Pharma Inc | 90.66M |
Allogene Therapeutics Inc | 512.23M |
AIM ImmunoTech Inc | 10.23M |
Protalix BioTherapeutics Inc | 33.57M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 91.83M |
Total Liabilities (Quarterly) | 34.02M |
Current Ratio | 3.318 |